securities fraud

Plug Power faces securities fraud lawsuit over alleged false statements about DOE loan program. Stock declined after executive departures and suspended loan activities.

Navan faces securities fraud lawsuit over IPO disclosure gaps regarding undisclosed sales expenses and slowing revenue growth. Stock fell 48% since offering.

Class action investigations launched against Ramaco Resources and Beyond Meat for alleged securities violations. Investors face deadlines of March 31 and March 24, 2026, respectively, to petition as lead plaintiffs.

Class action lawsuit filed against Navan alleging IPO disclosure failures on sales and marketing costs. Stock fell 64% from $25 to $9.01 since offering.

Ostin Technology faces class action lawsuit alleging securities fraud scheme involving fraudulent offerings and stock price manipulation that netted $110 million before collapsing 94%.

Law firm investigates Gemini Space Station after three senior executives abruptly resigned, causing stock to plummet 12.83%. Probe examines potential securities law violations.

Masonite faces securities fraud lawsuit for allegedly hiding Owens Corning acquisition talks while repurchasing stock. Investors have until April 2026 to join class action.

Rosen Law Firm investigates Lufax for potential disclosure violations after auditor removal announcement triggered 13.8% stock decline. Class action lawsuit evaluation ongoing.

Bath & Body Works faces securities class action lawsuit alleging false statements about business strategy and growth projections. Investors have until March 13, 2026 to request lead plaintiff status.

Law firm Block & Leviton investigates Gemini Space Station stock collapse following three executive departures and 75% price decline from IPO, citing potential securities law violations.

Law firm Hagens Berman investigates CoreWeave for allegedly misleading investors about AI infrastructure capacity and concealing Denton facility delays, triggering $14 billion market cap decline.

Bernstein Liebhard files class action lawsuit against Zynex for alleged overbilling scheme artificially inflating revenue from 2018-2023. Affected shareholders urged to evaluate legal options.

Law firm Bernstein Liebhard files class action lawsuit against Corcept Therapeutics for alleged material misrepresentations about relacorilant drug clinical evidence.

REGENXBIO faces class action lawsuit alleging false statements about gene therapy RGX-111's safety and efficacy. Investors must act by April 14, 2026 deadline.

uniQure faces class action lawsuit alleging misleading statements about FDA study status and BLA timeline delays. Investors who purchased shares Sept-Oct 2025 may be eligible to claim.

Oracle faces a class action lawsuit alleging it failed to disclose financial risks tied to its AI infrastructure investments, citing misaligned capital spending and revenue growth.

BellRing Brands faces class action lawsuit alleging it misrepresented sales growth as organic demand when it actually stemmed from customer inventory restocking following supply chain disruptions.

Class action lawsuit filed against Picard Medical for alleged securities fraud involving false statements, insider share sales, and social media misinformation to artificially inflate stock price.

REGENXBIO faces class action lawsuit alleging executives made false statements about RGX-111 gene therapy's efficacy and safety, seeking shareholder damages.

PomDoctor faces class action lawsuit alleging fraudulent stock promotion scheme involving false statements, insider sales, and market manipulation between October-December 2025.